Skip to main content

Abstract

Neuropsychiatric symptoms (NPS) are common in Parkinson’s disease (PD). The aim of this study was to estimate the correlates of NPS in patients with PD in the initial motor stage of the disease (hemiparkinsonism). A total of 111 patients with PD and 105 healthy control participants were assessed. Patients with PD experienced apathy, depression, and anxiety more frequently compared with healthy controls. Sleep disturbances occurred commonly in early PD patients. Patients with PD and mild cognitive impairment (MCI) had depression and anxiety more frequently, but not apathy, compared with patients with PD without MCI. The results of this study confirm a high burden of NPS even in the earliest motor stage of PD.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 205 - 210
PubMed: 26900739

History

Received: 4 October 2015
Revision received: 15 November 2015
Accepted: 21 November 2015
Published online: 22 February 2016
Published in print: Summer 2016

Authors

Details

Iva Stanković, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Elka Stefanova, M.D., Ph.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Aleksandra Tomić, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Milica Ječmenica Lukić, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Tanja Stojković, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Vladana Marković, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Gorana Mandić Stojmenović, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Nikola Kresojević, M.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Marina Svetel, M.D., Ph.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).
Vladimir Kostić, M.D., Ph.D.
From Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia (IS, ES, AT, MJL, TS, VM, GMS, NK, MS, VK); and School of Medicine, University of Belgrade, Belgrade, Serbia (ES, MS, VK).

Notes

Send correspondence to Dr. Kostić; e-mail: [email protected]

Competing Interests

Dr. Stefanova receives speaker’s honoraria from Novartis, Boehringer Ingelheim, Pfizer, and Lundbeck. Dr. Svetel receives speaker’s honoraria from Novartis, Boehringer Ingelheim, and GlaxoSmithKline. Dr. Kostić receives honoraria from Novartis, Boehringer Ingelheim, Pfizer, Lundbeck, GlaxoSmithKline, Swiss-Pharm, and Eurolek and a grant from SANU. All other authors report no financial relationships with commercial interests.

Funding Information

This work was supported by the Ministry of Education, Science, and Technological Development, Republic of Serbia (project no. 175090).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figures

Tables

Media

Share

Share

Share article link

Share